EVA1A and metabolic dysfunction-associated steatotic liver disease: In contrast, overexpression of EVA1A restores metabolic balance by inhibiting fatty acid uptake and enhancing β-oxidation, thereby inhibiting MASLD progression in ob/ob mice.